New
Cognitive Peptide Spray
Adalank Spray
N-Acetyl Selank AmidateAc-TKPRPGP-NH2Acetyl Selank amideSelank analog
A stabilized analog of Selank, N-acetyl Selank amidate (Ac-TKPRPGP-NH2), studied as a product-guide analog for Selank's GABAergic anxiolytic and BDNF-linked nootropic pathways. Adalank has no dedicated peer-reviewed studies of its own; the science shown reflects its parent compound, Selank. Premium Direct-Supply Peptide.
MassChoose an option
Quantity
From$115
Fast, protected deliveryTracked USA shipping with discreet packaging.
Tracked USA delivery
Free shipment protection
Priority shipping available
Frequently Paired Products
Products commonly selected alongside this item
Compound Information
Technical specifications
MOLECULAR PROFILE
What Is Adalank?
The Selank heptapeptide with both termini capped (N-acetyl + C-amide), studied as a longer-acting product surrogate for the Selank pathway.
HeptapeptideSelank analog
- Type
- Synthetic heptapeptide (Selank analog)
- Parent compound
- Selank (tuftsin-Pro-Gly-Pro)
- Sequence
- Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2
- Modifications
- N-terminal acetyl + C-terminal amide
- Amino Acids
- 7 residues (both termini capped)
- Molecular Formula
- Not published
- CAS Number
- Not assigned
PHYSICAL PROPERTIES
Handling & Storage
Supplied ready to use. No reconstitution required.
Ready to useProtect from direct light
- Appearance
- Clear, colorless solution
- Diluent
- Antimicrobial preserved water
- Storage
- 34°F to 120°F (1°C to 49°C)
- Shelf life
- Up to 8 months
DEVELOPMENT STATUS
Regulatory Information
A product-grade analog of Selank. Adalank itself is not an approved drug in any jurisdiction and has no dedicated clinical literature.
Parent compoundSelankDedicated studiesNone publishedUS StatusNot FDA-approvedUseproduct use only
Product Guides & References
Verified publications and source documentation
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S.S. KORSAKOVA
Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia
2008•PMID: 18454096Zozulia AA, Neznamov GG, Siuniakov TS, et al.
View Source BEHAVIOURAL NEUROLOGYPeptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats
2017•DOI: 10.1155/2017/5091027•PMID: 28280289Kasian A, Kolomin T, Andreeva L, et al.
View Source FRONTIERS IN PHARMACOLOGYSelank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
2016•DOI: 10.3389/fphar.2016.00031•PMID: 26924987Volkova A, Shadrina M, Kolomin T, et al.
View Source BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINESelank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats
2019•PMID: 31625062Kozlovskii II, Andreeva LA, Myasoedov NF
View Source ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S.S. KORSAKOVAA comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders
2014•PMID: 25176261Medvedev VE, Tereshchenko ON, Israelian AIu, et al.
View Source BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINEThe inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity
2001•PMID: 11550013Zozulya AA, Kost NV, Yu Sokolov O, et al.
View Source BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINEThe Influence of Selank on the Level of Cytokines Under Conditions of Experimental Immunodeficiency
2020•PMID: 32621722
View Source PHARMACOKINETIC DATA
